Mayo Clinic amyloid team receives 2022 Mayo Clinic Team Science Award, led by Martha Grogan, M.D., and Marina Ramirez-Alvarado, Ph.D.
A Mayo Clinic team led by Martha Grogan, M.D. (I ’87, CV ’94), Division of Structural Heart Disease at Mayo Clinic in Rochester; and Marina Ramirez-Alvarado, Ph.D. (MMED ’02), received the 2022 Mayo Clinic Team Science Award. The award recognizes team science — the unique and valuable contributions of different insights, skill sets and complementary expertise that are essential to succeed in discovering and translating scientific breakthroughs that address the unmet needs of patients.
Other members of the award-winning Mayo Amyloid Team are:
Omar Abou Ezzeddine, M.D. (I ’10, CV ’15, TXCV ’16, CTSA ’16), Department of Cardiovascular Disease, Mayo Clinic in Rochester
Mariam “Priya” Alexander, M.D. (APTH ’12), Department of Laboratory Medicine and Pathology, Mayo Clinic in Rochester
Surendra Dasari, Ph.D. (HSR ’12), Division of Computational Biology, Mayo Clinic in Rochester
Angela Dispenzieri, M.D. (I ’94, HEMO ’98), Division Hematology; Department of Laboratory Medicine and Pathology Mayo Clinic in Rochester, the Serene M. and Frances C. Durling Professorship
P. James Dyck, M.D. (PND ’96, NEMG ’97, PND ’99), Department of Neurology, Mayo Clinic in Rochester
Morie Gertz, M.D. (HEM ’83), Division Hematology, Mayo Clinic in Rochester, the Mayo Clinic Roland Seidler, Jr. Professorship in the Art of Medicine Honoring Dr. Michael Brennan
Taxiarchis Kourelis, M.D. (HEMO ’15, HEMA ’16), Division Hematology, Mayo Clinic in Rochester
Robert Kyle M.D. (I ’59), Emeritus Staff, Division of Hematology, Mayo Clinic in Rochester
Nelson Leung, M.D. (I ’97, NEPH ’00), Division of Nephrology and Hypertension, Mayo Clinic in Rochester
Michelle Mauermann, M.D. (PND ’07, NEMG ’08), chair, Division of Neuromuscular Medicine, Mayo Clinic in
Ellen McPhail, M.D. (I1 ’93, PATH ’97, SGPA ’98, HEMP ’99), Department of Laboratory Medicine and Pathology, Mayo Clinic in Rochester
Eli Muchtar, M.D. (HEMO ’14), Division of Hematology, Mayo Clinic in Rochester
David L. Murray, M.D., Ph.D. (PATH ’10), Division of Clinical Biochemistry and Immunology, Mayo Clinic in Rochester
Samih Nasr, M.D. (APTH ’09), Division of Anatomic Pathology, Mayo Clinic in Rochester
Julie Rosenthal, M.D. (CV ’16), Department of Cardiovascular Diseases, Mayo Clinic in Arizona
Taimur Sher, M.B.B.S., M.D. (HEMO ’11), Division of Hematology and Medical Oncology, Mayo Clinic in Florida
The Mayo Amyloid Team leads the field in research advancements and treatment of amyloidosis, a rare and complex condition that is fatal and incurable. Because of this transformative work, Mayo Clinic runs the largest amyloidosis treatment center in the U.S., and team members are recognized worldwide as experts in the disease and its treatment. The Mayo Clinic amyloid research program was started over 60 years ago by Robert Kyle, M.D., a nonagenarian who continues to publish in the field.
Patients with amyloidosis often struggle to coordinate care among multiple specialists; the Mayo Amyloid Team leverages expertise from a multitude of specialties, including hematology; cardiovascular disease; anatomic pathology; computational biology; neurology; nephrology and hypertension; hematopathology; clinical biochemistry; anatomic pathology; and molecular biology.